New Stock News | Mandi International Files with Hong Kong Stock Exchange

According to the disclosure by the Hong Kong Stock Exchange on November 20th, Mandi International has submitted its application to the Main Board of the Hong Kong Stock Exchange, with Huatai International as its exclusive sponsor. The prospectus reveals that Mandi International is a leading Chinese professional consumer healthcare company dedicated to developing and providing comprehensive and long-term solutions for skin health and weight management. The company primarily focuses on the hair health sector within the broader skin health industry and has established a leading position in this field. According to data from Frost & Sullivan, in terms of retail sales, Mandi International's flagship product Mandi series of minoxidil-based hair loss treatment products has ranked first in the Chinese hair loss drug market and minoxidil drug market for the past ten years since 2014, with market shares of approximately 57% and 71% respectively in those markets by 2024. In March 2025, Mandi International launched Mandi anti-hair loss shampoo, which is the first shampoo in China to add the ingredient of unoxygenated olefin to prevent hair loss. Within the first six months of its launch, it has sold over 500,000 bottles, redefining the landscape of the domestic hair loss and hair care market in China.